SMSbiotech, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-15.
SMSbiotech, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 15, 2025. Its industry group is Biotechnology. It names Abdulkader Rahmo, Ph.D. (Executive Officer, Director, Promoter), Harry Friedman (Executive Officer, Director), Ghassan Kassab (Director) (SEC Form D, October 15, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like SMSbiotech, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-15 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SMSbiotech, Inc.
Free to see. No signup.
More on the people and the money behind SMSbiotech, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in October 2025, largest first.
Get an email when SMSbiotech, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SMSbiotech, Inc. raises, hires or launches. No email unless you switch it on.
Watch SMSbiotech, Inc. →Get the full cited report on SMSbiotech, Inc.
What the filing shows about SMSbiotech, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SMSbiotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SMSbiotech, Inc.'s address as 1825 Diamond Street, Suite 101, San Marcos, CA 92078.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
SMSbiotech, Inc. is a registered filer with the SEC (CIK 2075778) and has filed since 2025-10-15. 1 filing is on record, the latest on 2025-10-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SMSbiotech, Inc.'s Form D of 2025-10-15 names Abdulkader Rahmo, Ph.D., Harry Friedman, Ghassan Kassab and 2 more as its officers, directors or promoters.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
SMSbiotech develops Small Mobile Stem cells, an allogeneic off-the-shelf platform. Investigational therapies in development for COPD and degenerative disease.
The title and description the site itself served, answering 200, after redirecting from https://smsbiotech.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Abdulkader Rahmo, Ph.D. is named as Executive Officer and Director and Promoter on the Form D that SMSbiotech, Inc. filed with the SEC on 15 October 2025, one of 5 people that filing names.
Harry Friedman is named as Executive Officer and Director on the Form D that SMSbiotech, Inc. filed with the SEC on 15 October 2025, one of 5 people that filing names.
Ghassan Kassab is named as Director on the Form D that SMSbiotech, Inc. filed with the SEC on 15 October 2025, one of 5 people that filing names.
Joseph Kiani is named as Director on the Form D that SMSbiotech, Inc. filed with the SEC on 15 October 2025, one of 5 people that filing names.
Mohamed Diab is named as Director on the Form D that SMSbiotech, Inc. filed with the SEC on 15 October 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-10-15 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SMSbiotech, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on SMSbiotech, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SMSbiotech, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SMSbiotech, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind SMSbiotech, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (smsbiotech.com).
Each opens in a new tab, filled in for SMSbiotech, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
https://mentionfox.com/funding/smsbiotech-inc-form-d-25000001